Federal appeals court rules against Trump administration on DACA

Judge orders that the DACA program be restarted Analysis from the ‘Special Report’ All-Star panel. A federal appeals court in San Francisco ruled against the Trump administration Thursday, saying the government cannot immediately end the DACA program that gives young undocumented immigrants a chance to continue living and working in the U.S. without the threat of deportation. The administration had […]

Read more

AG races could swell army of lawyers suing Trump, as Dems vow to ‘take on’ president

Florida AG candidate Sean Shaw, left, and Michigan AG candidate Dana Nessel, right, are among the Democratic candidates vying for the chance to engage in legal battle with President Trump.  (AP/Shaw campaign/Nessel campaign) Democrats don’t have to win control of either chamber of Congress to jam the Trump administration’s agenda and flood the zone with investigations. The state attorneys general […]

Read more

AG Jeff Sessions dispatches 5 more federal prosecutors to help Chicago with gun cases

WASHINGTON– Attorney General Jeff Sessions dispatched five additional federal prosecutors to Chicago Friday to assist in gun investigations, while serving notice that the Justice Department will oppose a pending agreement to overhaul local police department operations there. Sessions said the new prosecution unit would work with state and local authorities to “help ensure that Chicago’s most dangerous criminals are charged…disrupting the cycle […]

Read more

Senior China diplomat says confrontation with U.S. lose-lose

BEIJING (Reuters) – Confrontation between China and the United States means both sides lose, and talks with Washington cannot take place under threats and pressure, the Chinese government’s top diplomat State Councillor Wang Yi told U.S. business leaders. Meeting representatives of the U.S.-China Business Council and National Committee on United States-China Relations in New York, Wang said certain U.S. forces […]

Read more

Is CRISPR Therapeutics AG a Buy?

There's no hotter gene-editing stock on the market right now than CRISPR Therapeutics AG (NASDAQ: CRSP). It's up close to 130% so far in 2018, much higher than other biotechs that are also focused on developing gene-editing therapies. But CRISPR Therapeutics' market cap now stands at nearly $2.6 billion with no products on the market or even in clinical testing […]

Read more